• Issue

    Annals of Neurology: Volume 93, Issue 3

    C1, i-vi, 427-639
    March 2023

Cover Image

Free Access

Annals of Neurology: Volume 93, Number 3, March 2023

  • Page: C1
  • First Published: 24 February 2023

Issue Information

Free Access

Issue Information

  • Pages: i-vi
  • First Published: 24 February 2023

Research Articles

Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome

  • Pages: 604-614
  • First Published: 18 November 2022
Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome

This multi-center, randomized, double-blinded trial by Okuda, et al. assessed the impact of dimethyl fumarate (DMF) in the time to onset of first clinical symptoms attributable to a central nervous system (CNS) demyelinating event within a follow-up period of 96 weeks. Treatment with DMF resulted in over 80% risk reduction relative to placebo in the prevention of a first acute clinical event related to multiple sclerosis. A significant reduction in new and/or newly-enlarging T2-weighted hyperintense lesions was also observed.